Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine in acute exacerbation of schizophrenia
NCT00404573Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- Nov 2006
- Primary completion
- Aug 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cariprazine in schizophrenia (3 arms), sponsored by Forest Laboratories. Primary endpoint: Positive and Negative Syndrome Scale Total Score. Started Nov 2006; status: completed.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00404573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404573.